HIV/AIDS: HIV RNA Control After Six Months of Potent Antiretroviral Therapy
INACTIVE REVIEW: This measure review is older than five years.
Percentage of patients aged 13 years and older with a diagnosis of HIV/AIDS, who had at least two medical visits during the measurement year, with at least 90 days between each visit, who are receiving potent antiretroviral therapy, who have a viral load < 200 copies/mL after at least 6 months of potent antiretroviral therapy
ACP does not support PQRS 162: “HIV/AIDS: HIV RNA Control After Six Months of Potent Antiretroviral Therapy.” Although RNA control is a desirable outcome of HIV treatment, assessment of it at an arbitrary interval is not necessarily a measure of high quality care. The timing of assessment of clinical outcomes should be determined by patient circumstances and may differ from the interval specified.